Tower Research Capital LLC (TRC) - SAB BIOTHERAPEUTICS INC ownership

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T111. A total of 12 filers reported holding SAB BIOTHERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2024$20.0%480.0%0.00%
Q1 2024$2
+100.0%
480.0%0.00%
Q4 2023$1
-75.0%
480.0%0.00%
Q3 2023$4
-20.0%
480.0%0.00%
Q2 2023$5480.0%0.00%
Q1 2023$0480.0%0.00%
Q4 2022$0480.0%0.00%
Q3 2022$0480.0%0.00%
Q2 2022$0480.0%0.00%
Q1 2022$0480.0%0.00%
Q4 2021$0480.00%
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Yakira Capital Management, Inc. 108,485$5,1420.00%
Shaolin Capital Management LLC 249,143$11,8090.00%
MILLENNIUM MANAGEMENT LLC 62,500$2,9620.00%
WOLVERINE ASSET MANAGEMENT LLC 15,319$7260.00%
Walleye Trading LLC 15,505$7350.00%
Tower Research Capital LLC (TRC) 48$20.00%
MORGAN STANLEY 146,439$6,9410.00%
LMR Partners LLP 539,588$25,5760.00%
BANK OF AMERICA CORP /DE/ 200$90.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders